Diabetes Drug Leads to Weight Loss for People With Obesity – TODAY
People who took the drug Tirzepatide lost an average of 35 pounds (16 kilograms) on the 5-milligram dose, 49 pounds (22 kilograms) on the 10-milligram dose, and 52 pounds (23.6 kilograms) on the 15-milligram dose.
People without diabetes lost an average of 15% to 20.9% of their starting body weight over the course of a 72-week double-blind, randomized clinical trial. People with diabetes lost an average of 15% of their starting body weight.
In a new study, people with a BMI over 30 or over 27 who had at least one weight-related health condition were given weekly injections of Tirzepatide.
Participants in the study had an average starting weight of 231 pounds (104.8 kilograms) Over the course of the study the participants had to inject Tirzepatide once a week. Using a small needle. They also received counseling to help them stay on a healthy diet and exercise.
Researchers say Tirzepatide may help people with obesity by targeting the underlying causes of the disease.
For more on this story, please consider these sources:
- Diabetes Drug Leads to Weight Loss for People With Obesity TODAY
- This new diabetes drug could be a game changer for obesity | JUST THE FAQS USA TODAY
- Overweight people lost 35 to 52 pounds on newly approved diabetes drug, study says CNN
- Diabetes Drug Could Be Game Changer For Obesity And Weight Loss TODAY
- New diabetes drug helped obese people without the disease lose incredible amounts of weight Boing Boing
- View Full Coverage on Google News